Results 241 to 250 of about 394,507 (347)

Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study.

American Journal of Kidney Diseases, 2012
A. Anderson, Wei Yang, Chi-yuan Hsu, M. Joffe, M. Leonard, D. Xie, J. Chen, T. Greene, B. Jaar, Patricia F. Kao, J. Kusek, J. Landis, J. Lash, R. Townsend, M. Weir, H. Feldman   +15 more
semanticscholar   +1 more source

Human vs. artificial intelligence: Physicians outperform ChatGPT in real‐world pharmacotherapy counselling

British Journal of Clinical Pharmacology, EarlyView.
Aims To assess the utility of the artificial intelligence (AI) chatbot ChatGPT (openly available version 3.5) in responding to real‐world pharmacotherapeutic queries from healthcare professionals. Methods Three independent and blinded evaluators with different levels of medical expertise and professional experience (beginner, advanced, and expert ...
Benjamin Krichevsky, Stefan Engeli, Stefanie M. Bode‐Böger, Felix Koop, Martin Schulze Westhoff, Sebastian Schröder, Carsten Schumacher, Thorben Pape, Dirk O. Stichtenoth, Johannes Heck   +9 more
wiley   +1 more source

Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data.

Journal of the American College of Cardiology, 2014
K. Damman, W. W. Tang, G. M. Felker, Johan Lassus, F. Zannad, H. Krum, John J.V. McMurray   +6 more
semanticscholar   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

A new challenge for linagliptin: diabetes, organ transplantation and chronic renal insufficiency in the same patient

, 2018
Benedetta Maria Bonora
openalex   +2 more sources

Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency: a systematic review and meta-analysis.

Nephrology, Dialysis and Transplantation, 2013
Xiuhua Lu, Zhenghui Xiao, Mei-yu Yang, Yi-min Zhu   +3 more
semanticscholar   +1 more source

Understanding the influence of transfusion and blood loss on tranexamic acid concentration in scoliosis surgery with blood loss

British Journal of Clinical Pharmacology, EarlyView.
Aims Tranexamic acid (TXA) stabilizes clot formation by inhibiting fibrin degradation and improves postoperative outcomes. However, rare adverse events (e.g., thrombosis, seizures) warrant dose–risk evaluation. This study examines how perioperative blood loss and transfusion practices affect TXA concentrations during paediatric scoliosis surgery ...
Paula Alexandra Sá, Luisa Barreiros, Marcela A. Segundo, Eugénia Cruz, Sibylle Langenecker   +4 more
wiley   +1 more source

Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. [PDF]

Am J Kidney Dis
Wulczyn KE, Shafi T, Anderson A, Rincon-Choles H, Clish CB, Denburg M, Feldman HI, He J, Hsu CY, Kelly T, Kimmel PL, Mehta R, Nelson RG, Ramachandran V, Ricardo A, Shah VO, Srivastava A, Xie D, Rhee EP, Kalim S, CRIC Study Investigators.   +20 more
europepmc   +1 more source

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta, Luigi Angelo Fiorito, Roberta Vescovo, Anna Virgilio, Giulia Amato, Giuseppe Cimino   +5 more
wiley   +1 more source

Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study.

A M A Archives of Ophthalmology, 2012
J. Grunwald, J. Alexander, G. Ying, M. Maguire, Ebenezer Daniel, Revell Whittock-Martin, Candace Parker, K. McWilliams, J. Lo, A. Go, R. Townsend, C. Gadegbeku, J. Lash, J. Fink, Mahboob Rahman, H. Feldman, J. Kusek, D. Xie, B. Jaar   +18 more
semanticscholar   +1 more source